These 4 Biotech Penny Stocks Are Buys, According to Analysts
Four biotech penny stocks with upside to analyst price targets ranging from 42% to 291%.
Four biotech penny stocks with upside to analyst price targets ranging from 42% to 291%.
or these five stocks – which include a smaller cap mining company and a small-cap biotech play focused on developing specialty products for underserved patient… Read More »5 Buy-Rated Stocks Priced Under $10 Offering Solid Alpha Potential
The author of today’s article notes that high-profile IPOs typically follow a pattern – and given this pattern, he is bullish on “a biotech stock… Read More »This Recent Biotech IPO Has The Right Story At The Right Time – And The Right Pattern
2020 Top Stock Picker shares insights on the outlook for genomics, electric vehicles, blockchain technology and more.
Small- And Mid-Cap Biotech Picks For 2021 and holdovers from 2020.
Now, as 2021 begins, the author of today’s article believes that the “next decade could easily be the best decade, ever, for the stock market… Read More »How To Capitalize On What Could Be “The Best Decade, Ever, For The Stock Market”
When it comes to biotech investing in 2021, healthcare stock analysts at RBC advised in a recent report that “Many pandemic-related influences are setting up… Read More »Why Individual Stock Selection Will Be Key For Biotech Investors In 2021 – And RBC’s 15 Top Ideas
“Since we know small-cap stocks are hot and biotech stocks are as well, it might make sense to follow some smaller biotech penny stocks this… Read More »4 Biotech Penny Stocks To Watch Right Now – Including A Truly Psychedelic Stock
One-size-fits-all drugs are giving way to precision medicine, which the author of today’s article expects will come to dominate the health care marketplace in the… Read More »1 Buy And 1 Sell To Prepare Your Portfolio For The Precision Medicine Mega Trend
On Monday, the small biotech stock highlighted in today’s article hit a record high, skyrocketing 95.1%. The catalyst?